Argenta announces integrated drug discovery collaboration with Boehringer Ingelheim
17 April 2013 | By Zyme Communications
Argenta has signed a collaboration agreement with Boehringer Ingelheim...
List view / Grid view
News
B&W Tek announces enhanced NanoRam handheld raman spectrometer
17 April 2013 | By B&W Tek, Inc.
B&W Tek, Inc., is proud to announce major enhancements to their NanoRam handheld Raman spectrometer...
Sanofi reinforces its presence in Morocco
17 April 2013 | By Sanofi
Sanofi announced the opening of its new logistics hub in Casablanca, Morocco...
Tecan Academy offers on-demand, web-based training
16 April 2013 | By kdm communications limited
Tecan has launched a new online training tool that makes it easier than ever before for customers to optimize their instrument use...
Abbott introduces next generation laboratory automation solution to help meet increased testing demand
Abbott today announced the global launch of the ACCELERATOR® a3600, a next generation automation solution, to help laboratories address the need to process tests faster while handling increased volume. Advances in technology and automation within the lab have led to more timely results leading to improved patient care. Automation systems…
Merck opens new manufacturing facility in Hangzhou, China
16 April 2013 | By Merck
New facility to deliver innovative, high-quality Merck medicines to Asia...
Thermo Fisher Scientific to acquire Life Technologies Corporation
Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, and Life Technologies Corporation (NASDAQ: LIFE), a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the…
Roche and Ascletis enter collaboration to advance treatment options for Chinese patients with Hepatitis C
15 April 2013 | By Roche
Roche and Ascletis have entered into a collaboration...
Roche Group posts strong sales growth in the first quarter
11 April 2013 | By Roche
Group sales increase 6% at CER1 to 11.6 billion Swiss francs...
Sanofi and PATH announce the launch of large-scale production of semisynthetic artemisinin against Malaria
11 April 2013 | By Sanofi
A pivotal milestone in the fight against malaria...
Palbociclib receives FDA Breakthrough Therapy designation for potential treatment of patients with breast cancer
10 April 2013 | By Pfizer
Palbociclib has received Breakthrough Therapy designation...
Galectin-3 test provides doctors in Europe with new tool for assessing the prognosis of chronic heart failure patient
Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT Galectin-3 assay, a test to aid doctors in assessing the prognosis of patients diagnosed with chronic heart failure (HF). The test was developed in partnership with BG Medicine, Inc., (NASDAQ: BGMD) to run on Abbott’s ARCHITECT immunochemistry platform.
Merck announces FDA acceptance of New Drug Application for an investigational tablet formulation of the antifungal NOXAFIL® (posaconazole)
10 April 2013 | By Merck
Merck is seeking FDA approval of NOXAFIL...
Bristol-Myers Squibb Foundation, Morehouse School of Medicine partner
10 April 2013 | By Bristol-Myers Squibb Company
Creation of the Morehouse School of Medicine/Bristol-Myers Squibb Foundation Partnership...
Diabetes on the agenda in Mexico
9 April 2013 | By Novo Nordisk
The first-ever Diabetes Forum takes place in Mexico City (9th April), to address the critical diabetes challenge the country is facing...
